Mycobacterium tuberculosis: immune evasion, latency and reactivation.
about
Whole genome sequencing of Mycobacterium tuberculosis reveals slow growth and low mutation rates during latent infections in humansProteomic Analysis of Drug-Resistant Mycobacteria: Co-Evolution of Copper and INH ResistanceTackling tuberculosis: Insights from an international TB Summit in LondonInfluence of diabetes mellitus on the immunity to human tuberculosis.Meta-analysis of host response networks identifies a common core in tuberculosis.Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis.Pathogen evolution and the immunological niche.Manipulation of the mononuclear phagocyte system by Mycobacterium tuberculosis.Complement C4 deficiency--a plausible risk factor for non-tuberculous mycobacteria (NTM) infection in apparently immunocompetent patients.Mycobacterium tuberculosis pellicles express unique proteins recognized by the host humoral response.The proprotein convertase subtilisin/kexin furinA regulates zebrafish host response against Mycobacterium marinum.Granulocytic myeloid derived suppressor cells expansion during active pulmonary tuberculosis is associated with high nitric oxide plasma level.Collectin CL-LK Is a Novel Soluble Pattern Recognition Receptor for Mycobacterium tuberculosisConsumption of Oxidized Soybean Oil Increased Intestinal Oxidative Stress and Affected Intestinal Immune Variables in Yellow-feathered BroilersMycobacterial induction of autophagy varies by species and occurs independently of mammalian target of rapamycin inhibitionMycobacterium tuberculosis Peptidyl-Prolyl Isomerases Also Exhibit Chaperone like Activity In-Vitro and In-VivoCD4(+)CD25(-)Foxp3(+) T cells play a role in tuberculous hydrothorax rather than malignant hydrothorax.Different Risk of Tuberculosis and Efficacy of Isoniazid Prophylaxis in Rheumatoid Arthritis Patients with Biologic Therapy: A Nationwide Retrospective Cohort Study in TaiwanIn vitro and in vivo Evaluation of Synergism between Anti-Tubercular Spectinamides and Non-Classical Tuberculosis AntibioticsAssessments of serum copper and zinc concentration, and the Cu/Zn ratio determination in patients with multidrug resistant pulmonary tuberculosis (MDR-TB) in Côte d'IvoireDifferential trafficking of TLR1 I602S underlies host protection against pathogenic mycobacteria.Uncomplicated Urinary Tract Infections and Antibiotic Resistance-Epidemiological and Mechanistic AspectsKinetics of IFN-gamma and TNF-alpha gene expression and their relationship with disease progression after infection with Mycobacterium tuberculosis in guinea pigs.Disruption of immune regulation by microbial pathogens and resulting chronic inflammation.Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccines.PPE2 protein of Mycobacterium tuberculosis may inhibit nitric oxide in activated macrophages.Outcome of Mycobacterium tuberculosis and Toll-like receptor interaction: immune response or immune evasion?T cells and adaptive immunity to Mycobacterium tuberculosis in humans.Diagnosis and Management of Latent Tuberculosis Infection.DNA Replication in Mycobacterium tuberculosis.Immunization with alkyl hydroperoxide reductase subunit C reduces Fusobacterium nucleatum load in the intestinal tract.A Macrophage Infection Model to Predict Drug Efficacy Against Mycobacterium Tuberculosis.Role of TNF-Alpha, IFN-Gamma, and IL-10 in the Development of Pulmonary Tuberculosis.Mycobacterium tuberculosis... Can we beat it? Report from a Euroscicon conference 2013.Synthesis, characterization, and efficacy of antituberculosis isoniazid zinc aluminum-layered double hydroxide based nanocompositesFoxp3 expression and nitric oxide production in peripheral blood mononuclear cells of communicants with pulmonary tuberculosis.Autophagy induction by Mycobacterium indicus pranii promotes Mycobacterium tuberculosis clearance from RAW 264.7 macrophages.Host Antimicrobial Peptides: The Promise of New Treatment Strategies against Tuberculosis.Regulation of Three Virulence Strategies of Mycobacterium tuberculosis: A Success Story.Immunization with Single Oral Dose of Alginate-Encapsulated BCG Elicits Effective and Long-Lasting Mucosal Immune Responses.
P2860
Q28540725-5AEB4508-38EA-44AA-99EE-6573A0E437A3Q28547746-48D65BBF-995D-4CF8-8BB3-312FBC53BC68Q28602294-3C876731-75D7-4774-9BA1-C61265480968Q30234363-CE245B37-144E-419F-8233-B07A6EE01781Q33731336-CECF645E-FE66-4324-A95C-6764FDC3A9CCQ33791961-FADC8890-1616-4FD2-9BEC-F9B8C7750E10Q34078369-3C7835FA-0AC9-41F2-A373-6910D7872E82Q34400291-ABFAD375-9D6E-4507-AEEE-2D0266DA4414Q35123251-E2848052-8D0A-4FC6-8D39-D3B0CFC10D52Q35186462-8780D883-DB3A-452E-BB4D-0EDA58A3FD2BQ35187534-6149DC90-B94D-471A-BF91-CF2F5881276EQ35448784-0BE4BFA3-C99F-4A8C-9D36-66A052A32688Q35691023-F0A59679-FB31-4F07-B115-290F46BAE2CBQ35773790-FBFE7F51-56AB-412D-B501-841B53830775Q35921566-AEBA3A79-2475-40C4-B26F-EF9BD40EEFD9Q35959194-9B18EB82-AAEA-4610-B2C3-56DFC89AA884Q35964725-19534974-73EA-4D5B-8E27-E4A68B5C9B43Q35985497-04431028-5151-42BA-AC80-FF2E030B80DAQ36056408-74E9492E-E99F-46D8-B0A3-953181FA4022Q36343709-77E295F7-AECC-40D8-8650-4EFA96C1A8D5Q36417345-1A7373F2-BA44-4502-9CEB-67B923E5C4C7Q36683661-64FDF678-C6EB-460A-8904-1BBB7F5F5F8EQ36793138-45A333C2-8747-4063-95F6-E7C1AC4DA35AQ37716173-6F189FDC-A47C-4CB5-9ECE-C97037C47498Q38059150-B0BE9252-325B-4B26-AFD6-9FE4A59613D2Q38085418-07D03D2A-24B6-431B-956C-D819F838C5CEQ38225182-6F5C0165-9281-4A36-AA4A-BC94F1F11F0BQ38363792-FC8759ED-A6FF-4DF1-8699-3FA46918CE26Q38520964-E5B74403-5E44-4C00-AFD6-E4903FC8AA1EQ39210590-E38C9EC2-1F7D-498B-8ED9-E8DAD2C1A2CDQ40065611-AA2C4CF3-78DD-4FAB-9A03-9274577E4D9DQ41529160-CA2BCA2B-02A8-44EE-9CBB-D755870516D5Q41817065-131EE703-D64D-444A-BC2A-DF8CBA91A210Q42314991-DEA8B25B-D349-4A34-89D4-46CCC84DAF4FQ42409179-C0E6798B-4F2A-4273-9E3F-1E12E25DE341Q43537065-64A84368-A49D-4B06-952F-10D771884DD6Q46242131-6F4FC885-8295-4E78-A789-C5D7BA01D706Q47093744-8E4499BA-F555-4F4F-BFC0-60F4CDF019BBQ48175634-8635575E-3F60-4CC9-9A50-8EF102CA1056Q51602972-21375244-D55B-43ED-B936-FEAC36060FB0
P2860
Mycobacterium tuberculosis: immune evasion, latency and reactivation.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Mycobacterium tuberculosis: immune evasion, latency and reactivation.
@en
Mycobacterium tuberculosis: immune evasion, latency and reactivation.
@nl
type
label
Mycobacterium tuberculosis: immune evasion, latency and reactivation.
@en
Mycobacterium tuberculosis: immune evasion, latency and reactivation.
@nl
prefLabel
Mycobacterium tuberculosis: immune evasion, latency and reactivation.
@en
Mycobacterium tuberculosis: immune evasion, latency and reactivation.
@nl
P2093
P1433
P1476
Mycobacterium tuberculosis: immune evasion, latency and reactivation
@en
P2093
Akshay Kaul
Anthony G Tsolaki
Antima Gupta
Sanjib Bhakta
P304
P356
10.1016/J.IMBIO.2011.07.008
P50
P577
2011-07-18T00:00:00Z